Prognostic value of pre-treatment PNH clone among the patients with aplastic anemia: a meta-analysis

References

• Young NS. Aplastic anemia. N Engl J Med. 2018;379(17):1643–1656.
   PubMed Web of Science ®Google Scholar
• Hill A, DeZern AE, Kinoshita T, et al. Paroxysmal nocturnal haemoglobinuria. Nat Rev Dis Primers. 2017;3:17028.
   PubMed Web of Science ®Google Scholar
• Lewis SM, Dacie JV. The aplastic anaemia–paroxysmal nocturnal haemoglobinuria syndrome. Br J Haematol. 1967;13(2):236–251.
   PubMed Web of Science ®Google Scholar
• Ren X, Li X, Huo J, et al. Small PNH clones detected by fluorescent aerolysin predict a faster response to immunosuppressive therapy in patients with severe aplastic anaemia. Hematology. 2020;25(1):348–355.
   PubMed Web of Science ®Google Scholar
• Wang L, Liu H. Pathogenesis of aplastic anemia. Hematology. 2019;24(1):559–566.
   PubMed Web of Science ®Google Scholar
• Sugimori C, Chuhjo T, Feng X, et al. Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia. Blood. 2006;107(4):1308–1314.
   PubMed Web of Science ®Google Scholar
• Narita A, Muramatsu H, Sekiya Y, et al. Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia. Haematologica. 2015;100(12):1546–1552.
   PubMed Web of Science ®Google Scholar
• Li YM, Li XX, Ge ML, et al. The clinical significance of evolution of paroxysmal nocturnal haemoglobinuria clones in aplastic anemia patients. Chin J Hematol. 2012;33(2):117–122.
   Google Scholar
• Zhang J, Li XX, Shi J, et al. Clinical characteristics and evolution of paroxysmal nocturnal hemoglobinuria clones in patients with acquired aplastic anemia. Chin J Hematol. 2016;37(2):124–129.
   Google Scholar
• Sun YX, Zhu MQ, He GS, et al. The variation and clinical significance of paroxysmal nocturnal hemoglobinuria clone in patients with aplastic anemia before and after immunosuppressive therapy. Chin J Intern Med. 2013;52(7):585–589.
   PubMedGoogle Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–605.
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–1101.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey SG, Schneider M. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997;315:629–634.
   PubMed Web of Science ®Google Scholar
• Dunn DE, Tanawattanacharoen P, Boccuni P, et al. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med. 1999;131(6):401–408.
   PubMed Web of Science ®Google Scholar
• Yoshida N, Yagasaki H, Takahashi Y, et al. Clinical impact of HLA-DR15, a minor population of paroxysmal nocturnal haemoglobinuria-type cells, and an aplastic anaemia-associated autoantibody in children with acquired aplastic anaemia. Br J Haematol. 2008;142(3):427–435.
   PubMed Web of Science ®Google Scholar
• Scheinberg P, Wu CO, Nunez O, et al. Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. Br J Haematol. 2009;144(2):206–216.
   PubMed Web of Science ®Google Scholar
• Kulagin A, Lisukov I, Ivanova M, et al. Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study. Br J Haematol. 2014;164(4):546–554.
   PubMed Web of Science ®Google Scholar
• Timeus F, Crescenzio N, Longoni D, et al. Paroxysmal nocturnal hemoglobinuria clones in children with acquired aplastic anemia: a multicentre study. PLoS One. 2014;9(7):e101948.
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhang L, Jing L, et al. The role of paroxysmal nocturnal hemoglobinuria clones in response to immunosuppressive therapy of patients with severe aplastic anemia. Ann Hematol. 2015;94(7):1105–1110.
   PubMed Web of Science ®Google Scholar
• Shao HJ, Ji ZH, Miu MH, et al. Analysis of the role of paroxysmal nocturnal hemoglobinuria clones in acquired aplastic anemia in children(in Chinese). J Clin Pediatrics. 2018;36(03):192–196.
   Google Scholar
• Liu LP, Chen XJ, Yang WY, et al. Predicting response to porcine antilymphocyte globulin plus cyclosporine A in children with acquired severe aplastic anemia. Pediatr Res. 2019;86(3):360–364.
   PubMed Web of Science ®Google Scholar
• Chen JJ, Liu KK, Chu JH, et al. Long-term clinical study on efficacy of combined immunosuppressive therapy in aplastic anemia in children(in Chinese). J China Pediatric Blood and Cancer. 2020;25(03):133–137.  + 143.
   Google Scholar
• Wang H, Liu H, Wang T, et al. Relationship between immune status after ATG treatment and PNH clone evolution in patients with severe aplastic anemia. J Clin Lab Anal. 2021;35(3):e23667.
   PubMed Web of Science ®Google Scholar
• Camitta BM, Thomas ED, Nathan DG, et al. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood. 1979;53(3):504–514.
   PubMed Web of Science ®Google Scholar
• Red Blood Cell Disease (Anemia) Group, Chinese Society of Hematology, Chinese Medical Association. Chinese expert consensus on the diagnosis and treatment of aplastic anemia. Chin J Hematol. 2017;38(1):1–5.
   Google Scholar
• Babushok DV, Perdigones N, Perin JC, et al. Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia. Cancer Genet. 2015;208(4):115–128.
   PubMed Web of Science ®Google Scholar
• Sun L, Babushok DV. Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria. Blood. 2020;136(1):36–49.
   PubMed Web of Science ®Google Scholar
• Hanaoka N, Kawaguchi T, Horikawa K, et al. Immunoselection by natural killer cells of PIGA mutant cells missing stress-inducible ULBP. Blood. 2006;107(3):1184–1191.
   PubMed Web of Science ®Google Scholar
• Sutherland DR, Kuek N, Azcona-Olivera J, et al. Use of a FLAER-based WBC assay in the primary screening of PNH clones. Am J Clin Pathol. 2009;132(4):564–572.
   PubMed Web of Science ®Google Scholar
• Luzzatto L. PNH phenotypes and their genesis. Br J Haematol. 2020;189(5):802–805.
   PubMed Web of Science ®Google Scholar
• Illingworth A, Marinov I, Sutherland DR, et al. ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 3 - data analysis, reporting and case studies. Cytometry B Clin Cytom. 2018;94(1):49–66.
   PubMed Web of Science ®Google Scholar